Prevalence of herpes zoster virus reactivation in patients diagnosed with Bell's palsy

OBJECTIVE: Herpes zoster virus can cause inflammatory neuropathy of the facial nerve. However, studies evaluating the prevalence of this agent in peripheral facial palsy are heterogeneous regarding sample group selection, laboratory analysis method and variables studied. In addition, there are a lack of epidemiological data in the Brazilian population on this serological phenomenon in peripheral facial palsy. This study estimated herpes zoster reactivation prevalence in serological samples through chemiluminescence immunoassay for quantitative determination of specific antibodies directed against the virus.

METHODS: This cross-sectional study sought to determine the prevalence of viral reactivation by herpes zoster in subjects with idiopathic peripheral facial palsy through analysis of serological samples over a year.

RESULTS: Forty-seven patients (32 females and 15 males) participated. Severe paralysis was more common in older patients (p = 0.017). Facial pain (p = 0.02) and vertigo (p = 0.001) were related to a worse evolution of facial palsy. The rate of serological reactivation of the virus was 12.76 per cent.

CONCLUSION: The rate of serological reactivation of herpes virus in idiopathic peripheral facial palsy in our population is similar to foreign literature data, suggesting similar aetiological mechanisms in the genesis of this morbidity.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:136

Enthalten in:

The Journal of laryngology and otology - 136(2022), 10 vom: 25. Okt., Seite 975-978

Sprache:

Englisch

Beteiligte Personen:

Freire de Castro, R [VerfasserIn]
Crema, D [VerfasserIn]
Neiva, F C [VerfasserIn]
Pinto, R A S R [VerfasserIn]
Suzuki, F A [VerfasserIn]

Links:

Volltext

Themen:

Antibodies, Viral
Bell Palsy
Chickenpox
Herpes Zoster
Journal Article
Varicella Zoster Virus Infection
Zoster Sine Herpete

Anmerkungen:

Date Completed 28.09.2022

Date Revised 28.09.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1017/S0022215121004631

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM336104839